Last update 26 Dec 2024
BGT-007
Last update 26 Dec 2024
Overview
Basic Info
Drug Type T-lymphocyte cell therapy |
Synonyms BGT 007, BGT-007, BGT007 + [1] |
Target- |
Mechanism T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with BGT-007Exploratory Clinical Study Initiated by Researchers on the Safety and Preliminary Efficacy of BGT007 in Treating Patients with Recurrent/refractory Gastrointestinal Malignancies
Clinical Study on the Safety and Initial Efficacy of BGT007H Cell Therapy in Patients With Recurrent/Metastatic Refractory Digestive Tract Tumors
Clinical Study on the Safety and Initial Efficacy of BGT007 Cell Therapy in Patients With Recurrent/Metastatic Refractory Digestive Tract Tumors
100 Clinical Results associated with BGT-007
Login to view more data
100 Translational Medicine associated with BGT-007
Login to view more data
100 Patents (Medical) associated with BGT-007
Login to view more data
100 Deals associated with BGT-007
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Intestinal preparation | Phase 1 | - |  BioSyngen Pte Ltd.Startup | 30 Nov 2024 |
| Gastrointestinal Neoplasms | Phase 1 | CN | BioSyngen Pte Ltd.Startup | 09 Oct 2023 |
| Nasopharyngeal Cancer, Recurrent | Phase 1 | CN | 30 Dec 2022 | |
| Nasopharyngeal Carcinoma | Phase 1 | CN | 30 Dec 2022 | |
| Colorectal Cancer | Phase 1 | - | BioSyngen Pte Ltd.Startup | - |
| Endometrial Carcinoma | Phase 1 | - | BioSyngen Pte Ltd.Startup | - |
| Pancreatic Ductal Adenocarcinoma | Phase 1 | - | BioSyngen Pte Ltd.Startup | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free